P Raanani

Summary

Affiliation: Tel Aviv University
Country: Israel

Publications

  1. ncbi request reprint Is cure of chronic myeloid leukemia in the third millennium a down to earth target (ed) or a castle in the air?
    Pia Raanani
    Institute of Hematology, Davidoff Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Electronic address
    Cancer Lett 352:21-7. 2014
  2. doi request reprint Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis
    Pia Raanani
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    Leuk Lymphoma 50:764-72. 2009
  3. doi request reprint Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis
    Pia Raanani
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    J Clin Oncol 27:770-81. 2009
  4. ncbi request reprint Extramedullary disease and targeted therapies for hematological malignancies--is the association real?
    P Raanani
    Institute of Hematology, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel
    Ann Oncol 18:7-12. 2007
  5. ncbi request reprint Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?
    P Raanani
    Rabin Medical Center, Department of Hematology, Isreal
    Ann Oncol 17:117-22. 2006
  6. ncbi request reprint Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis
    Pia Raanani
    Institute of Hematology, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Acta Haematol 113:181-9. 2005
  7. ncbi request reprint Assessment of the response to imatinib in chronic myeloid leukemia patients--comparison between the FISH, multiplex and RT-PCR methods
    Pia Raanani
    The Institute of Hematology, The Chaim Sheba Medical Center, Tel Hashomer, Israel
    Eur J Haematol 73:243-50. 2004
  8. ncbi request reprint Detection of minimal residual disease in acute myelogenous leukemia
    P Raanani
    Institute of Hematology, Chaim Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Acta Haematol 112:40-54. 2004
  9. ncbi request reprint Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA--a manifestation of the basic disease or the treatment
    P Raanani
    Institute of Hematology, The Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel
    Leuk Lymphoma 37:605-10. 2000
  10. ncbi request reprint Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma
    A Avigdor
    Institute of Hematology, The Chaim Sheba Medical Center Tel Hashomer, Israel
    Leuk Lymphoma 42:683-7. 2001

Detail Information

Publications13

  1. ncbi request reprint Is cure of chronic myeloid leukemia in the third millennium a down to earth target (ed) or a castle in the air?
    Pia Raanani
    Institute of Hematology, Davidoff Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Electronic address
    Cancer Lett 352:21-7. 2014
    ....
  2. doi request reprint Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis
    Pia Raanani
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    Leuk Lymphoma 50:764-72. 2009
    ..On the basis of the available data, IVIG cannot be recommended routinely for patients with CLL or MM with hypogammaglobulinemia and/or recurrent infections and should be considered on individual basis...
  3. doi request reprint Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis
    Pia Raanani
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    J Clin Oncol 27:770-81. 2009
    ....
  4. ncbi request reprint Extramedullary disease and targeted therapies for hematological malignancies--is the association real?
    P Raanani
    Institute of Hematology, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel
    Ann Oncol 18:7-12. 2007
    ..Since the use of these targeted therapies is expanding we should be aware of this association...
  5. ncbi request reprint Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?
    P Raanani
    Rabin Medical Center, Department of Hematology, Isreal
    Ann Oncol 17:117-22. 2006
    ..The clinical impact of fused PET/CT data on staging and patient management of Hodgkin disease (HD) and non-Hodgkin lymphoma (NHL) was assessed...
  6. ncbi request reprint Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis
    Pia Raanani
    Institute of Hematology, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Acta Haematol 113:181-9. 2005
    ..Although both entities carry a severe prognosis, differentiating between them might have clinical relevance, especially in the imatinib era...
  7. ncbi request reprint Assessment of the response to imatinib in chronic myeloid leukemia patients--comparison between the FISH, multiplex and RT-PCR methods
    Pia Raanani
    The Institute of Hematology, The Chaim Sheba Medical Center, Tel Hashomer, Israel
    Eur J Haematol 73:243-50. 2004
    ....
  8. ncbi request reprint Detection of minimal residual disease in acute myelogenous leukemia
    P Raanani
    Institute of Hematology, Chaim Sheba Medical Center, Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Acta Haematol 112:40-54. 2004
    ..Several issues still remain to be settled including the choice of the best method and the timing for MRD monitoring and above all the practical clinical implications of MRD in the various types of AML...
  9. ncbi request reprint Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA--a manifestation of the basic disease or the treatment
    P Raanani
    Institute of Hematology, The Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel
    Leuk Lymphoma 37:605-10. 2000
    ..Here we describe 2 patients who developed diffuse alveolar hemorrhage during treatment with ATRA. The possible mechanisms of pulmonary bleeding in these cases are discussed...
  10. ncbi request reprint Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma
    A Avigdor
    Institute of Hematology, The Chaim Sheba Medical Center Tel Hashomer, Israel
    Leuk Lymphoma 42:683-7. 2001
    ..We assume that a change in the expression of some adhesion molecules on the myeloma and/or the stromal cells is responsible for this phenomenon. Treating Physicians should be aware of this phenomenon in MM patients receiving thalidomide...
  11. ncbi request reprint Engraftment-associated hypophosphatemia--the role of cytokine release and steep leukocyte rise post stem cell transplantation
    P Raanani
    Institute of Hematology, Chaim Sheba Medical Center, Tel-Hashomer, Israel
    Bone Marrow Transplant 27:311-7. 2001
    ..We assume that both a direct effect of cytokine release and an increased consumption by the dividing WBCs contribute to its appearance. As its occurrence usually antedates engraftment it can be used as a forerunner for WBC recovery...
  12. doi request reprint Prophylaxis regimens for GVHD: systematic review and meta-analysis
    R Ram
    Institute of Hematology, Davidoff Center Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel
    Bone Marrow Transplant 43:643-53. 2009
    ..The addition of steroids did not affect the outcomes (four trials). We conclude that MTX-CsA and MTX-tacrolimus are both acceptable alternatives for GVHD prophylaxis, although MTX-tacrolimus may be superior in terms of aGVHD reduction...
  13. ncbi request reprint Widespread abdominal venous thrombosis in paroxysmal nocturnal hemoglobinuria diagnosed on CT
    G Gayer
    Department of Diagnostic Imaging, Sheba Medical Center, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer 52621, Israel
    Abdom Imaging 26:414-9. 2001
    ..This complication should be clinically suspected in patients suffering from paroxysmal nocturnal hemoglobinuria who present with abdominal pain, and it should be sought by the radiologist on pre- and postcontrast computed tomography...